SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-028251
Filing Date
2021-02-25
Accepted
2021-02-25 16:15:31
Documents
4
Period of Report
2021-02-19
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm217886d1_8k.htm 8-K 25225
2 EXHIBIT 10.1 tm217886d1_ex10-1.htm EX-10.1 79678
3 EXHIBIT 10.2 tm217886d1_ex10-2.htm EX-10.2 40355
4 GRAPHIC tm217886d1_ex10-1img001.jpg GRAPHIC 7526
  Complete submission text file 0001104659-21-028251.txt   157042
Mailing Address 5301 WISCONSIN AVENUE NW SUITE 570 WASHINGTON DC 20015
Business Address 5301 WISCONSIN AVENUE NW SUITE 570 WASHINGTON DC 20015 301-215-7440
Petros Pharmaceuticals, Inc. (Filer) CIK: 0001815903 (see all company filings)

IRS No.: 851410058 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39752 | Film No.: 21680521
SIC: 2834 Pharmaceutical Preparations